Form 4 for SGRY Surgery Partners, Inc.
Accepted 2023-03-28 00:00:00 ET · period of report 2023-03-24 · accession 0001638833-23-000054 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-28 | 2023-03-24 | SGRY | DeVeydt Wayne S | Exec COB, Dir | A - Grant | $0.00 | +20.4K | 219.0K | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-24 | A | A | 20,408 | $0.00 | 218,999 | D | — | — | (F1) The Compensation Committee approved this award of unrestricted common stock in lieu of, and in full settlement of, a portion of the cash incentive award earned by the Reporting Person under the Issuer's cash incentive plan for performance in 2022. |